Maze Therapeutics, Inc. (MAZE)
NASDAQ: MAZE · Real-Time Price · USD
25.88
-0.37 (-1.41%)
At close: Oct 8, 2026, 4:00 PM EDT
25.88
0.00 (0.00%)
After-hours: Oct 8, 2026, 4:43 PM EDT
Maze Therapeutics Stock Forecast
Stock Price Forecast
According to 13 analysts polled by S&P Global, Maze Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $61.5. The average 1-year stock price forecast is 137.64% higher than the current stock price, while the lowest is $46 (+77.74%) and the highest is $110 (+325.04%).
Price Target: $61.5 (+137.64%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Maze Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 11 | 11 | 11 | 12 | 12 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $110 | Buy | Maintains | $110 | +325.04% | Oct 5, 2026 |
| Wedbush | Wedbush | Buy Maintains $48 | Buy | Maintains | $48 | +85.47% | Sep 23, 2026 |
| BTIG | BTIG | Buy Maintains $46 | Buy | Maintains | $46 | +77.74% | Sep 23, 2026 |
| Citi | Citi | Buy Initiates $50 | Buy | Initiates | $50 | +93.20% | Sep 23, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $57 | Buy | Maintains | $57 | +120.25% | Sep 22, 2026 |
Financial Forecast
Revenue This Year
20.00M
Revenue Next Year
8.11M
from 20.00M
Decreased by -59.46%
EPS This Year
-2.74
from -3.05
EPS Next Year
-3.22
from -2.74
EPS and Forward PE are based on non-GAAP adjusted numbers.